NDC 72694-515

asparlas

Calaspargase Pegol

asparlas is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Servier Pharmaceuticals Llc. The primary component is Calaspargase Pegol.

Product ID72694-515_25fc7d15-4a8f-4c12-a603-aeeac73e4998
NDC72694-515
Product TypeHuman Prescription Drug
Proprietary Nameasparlas
Generic NameCalaspargase Pegol
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2019-09-27
Marketing CategoryBLA / BLA
Application NumberBLA761102
Labeler NameServier Pharmaceuticals LLC
Substance NameCALASPARGASE PEGOL
Active Ingredient Strength750 U/mL
Pharm ClassesAsparaginase [CS],Asparagine-specific Enzyme [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 72694-515-01

1 VIAL, SINGLE-USE in 1 CARTON (72694-515-01) > 5 mL in 1 VIAL, SINGLE-USE
Marketing Start Date2019-09-27
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72694-515-01 [72694051501]

asparlas INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA761102
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2019-09-27

Drug Details

Active Ingredients

IngredientStrength
CALASPARGASE PEGOL750 U/mL

OpenFDA Data

SPL SET ID:6585bd0d-bd78-4341-9e87-0f7664821f05
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 2121421
  • 2121426
  • UPC Code
  • 0372694515017
  • Pharmacological Class

    • Asparaginase [CS]
    • Asparagine-specific Enzyme [EPC]

    Trademark Results [asparlas]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ASPARLAS
    ASPARLAS
    87452086 5950575 Live/Registered
    SERVIER IP UK LIMITED
    2017-05-16

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.